Erlanger Health Systems

Chattanooga, Tennessee 37403

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Colorectal Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Renal Cell Carcinoma

Studies at this site

• A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy — Stopped early
• Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer — Completed
• A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) — Completed
• Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer — Status unconfirmed
• Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer — Completed
• Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer — Completed